{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T07:01:55Z","timestamp":1776322915959,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-026-02271-5","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T06:33:39Z","timestamp":1772519619000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CUX1::MET fusion defines an indolent subtype of diffuse low-grade glioma, MAPK pathway\u2013altered"],"prefix":"10.1186","volume":"14","author":[{"given":"Hiroaki","family":"Nagashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhide","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoe","family":"Jimbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadzki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Kimbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sasayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2271_CR1","doi-asserted-by":"publisher","first-page":"e13060","DOI":"10.1111\/bpa.13060","volume":"32","author":"TA Bale","year":"2022","unstructured":"Bale TA, Rosenblum MK (2022) The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors. Brain Pathol 32:e13060. https:\/\/doi.org\/10.1111\/bpa.13060","journal-title":"Brain Pathol"},{"key":"2271_CR2","doi-asserted-by":"publisher","unstructured":"Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555: 469\u2013474 https:\/\/doi.org\/10.1038\/nature26000","DOI":"10.1038\/nature26000"},{"key":"2271_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40478-024-01776-1","volume":"12","author":"N Chapman","year":"2024","unstructured":"Chapman N, Greenwald J, Suddock J, Xu D, Markowitz A, Humphrey M, Cotter JA, Krieger MD, Hawes D, Ji J (2024) Clinical, pathologic, and genomic characteristics of two pediatric glioneuronal tumors with a CLIP2::MET fusion. Acta Neuropathol Commun 12:63. https:\/\/doi.org\/10.1186\/s40478-024-01776-1","journal-title":"Acta Neuropathol Commun"},{"key":"2271_CR4","doi-asserted-by":"publisher","unstructured":"Davies KD, Ng TL, Estrada-Bernal A, Le AT, Ennever PR, Camidge DR, Doebele RC, Aisner DL (2017) Dramatic Response to Crizotinib in a Patient with Lung Cancer Positive for an HLA-DRB1-MET Gene Fusion. JCO Precis Oncol 2017. https:\/\/doi.org\/10.1200\/po.17.00117","DOI":"10.1200\/po.17.00117"},{"key":"2271_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4137\/tog.S30534","volume":"7","author":"I Garajov\u00e1","year":"2015","unstructured":"Garajov\u00e1 I, Giovannetti E, Biasco G, Peters GJ (2015) c-Met as a Target for Personalized Therapy. Transl Oncogenomics 7:13\u201331. https:\/\/doi.org\/10.4137\/tog.S30534","journal-title":"Transl Oncogenomics"},{"key":"2271_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.5114\/fn.2020.102437","volume":"58","author":"A Gilani","year":"2020","unstructured":"Gilani A, Davies K, Kleinschmidt-DeMasters B (2020) Histological features in pediatric central nervous system tumors with FGFR alterations. Folia Neuropathol 58:347\u2013356. https:\/\/doi.org\/10.5114\/fn.2020.102437","journal-title":"Folia Neuropathol"},{"key":"2271_CR7","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41467-019-12187-5","volume":"10","author":"AS Guerreiro Stucklin","year":"2019","unstructured":"Guerreiro Stucklin AS, Ryall S, Fukuoka K, Zapotocky M, Lassaletta A, Li C, Bridge T, Kim B, Arnoldo A, Kowalski PE al (2019) Alterations in ALK\/ROS1\/NTRK\/MET drive a group of infantile hemispheric gliomas. Nat Commun 10:4343. https:\/\/doi.org\/10.1038\/s41467-019-12187-5","journal-title":"Nat Commun"},{"key":"2271_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/po.18.00385","volume":"3","author":"MC Hiemenz","year":"2019","unstructured":"Hiemenz MC, Skrypek MM, Cotter JA, Biegel JA (2019) Novel TRIM24-MET Fusion in a Neonatal Brain Tumor. JCO Precis Oncol 3:1\u20136. https:\/\/doi.org\/10.1200\/po.18.00385","journal-title":"JCO Precis Oncol"},{"key":"2271_CR9","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3171\/2019.12.Jns192155","volume":"134","author":"Y Ishi","year":"2021","unstructured":"Ishi Y, Yamaguchi S, Hatanaka KC, Okamoto M, Motegi H, Kobayashi H, Terasaka S, Houkin K (2021) Association of the FGFR1 mutation with spontaneous hemorrhage in low-grade gliomas in pediatric and young adult patients. J Neurosurg 134:733\u2013741. https:\/\/doi.org\/10.3171\/2019.12.Jns192155","journal-title":"J Neurosurg"},{"key":"2271_CR10","doi-asserted-by":"crossref","unstructured":"Johnson A, Severson E, Gay L, Vergilio JA, Elvin J, Suh J, Daniel S, Covert M, Frampton GM, Hsu S et al (2017) Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures. Oncologist 22: 1478\u20131490","DOI":"10.1634\/theoncologist.2017-0242"},{"key":"2271_CR11","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1158\/0008-5472.Can-05-2749","volume":"66","author":"M Kong-Beltran","year":"2006","unstructured":"Kong-Beltran M, Seshagiri S, Zha J, Zhu W, Bhawe K, Mendoza N, Holcomb T, Pujara K, Stinson J, Fu Let al et al (2006) Somatic mutations lead to an oncogenic deletion of met in lung cancer. Cancer Res 66:283\u2013289. https:\/\/doi.org\/10.1158\/0008-5472.Can-05-2749","journal-title":"Cancer Res"},{"key":"2271_CR12","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger Get al et al (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro Oncol"},{"key":"2271_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1158\/1078-0432.CCR-21-1566","volume":"28","author":"LN Mathieu","year":"2022","unstructured":"Mathieu LN, Larkins E, Akinboro O, Roy P, Amatya AK, Fiero MH, Mishra-Kalyani PS, Helms WS, Myers CE, Skinner AMet al et al (2022) FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations. Clin Cancer Res 28:249\u2013254 Doi 10.1158\/1078\u2009\u2013\u20090432.Ccr-21-1566","journal-title":"Clin Cancer Res"},{"key":"2271_CR14","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/neuonc\/noab138","volume":"23","author":"T Milde","year":"2021","unstructured":"Milde T, Rodriguez FJ, Barnholtz-Sloan JS, Patil N, Eberhart CG, Gutmann DH (2021) Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas. Neuro Oncol 23:1634\u20131646. https:\/\/doi.org\/10.1093\/neuonc\/noab138","journal-title":"Neuro Oncol"},{"key":"2271_CR15","doi-asserted-by":"publisher","unstructured":"Navis AC, van Lith SA, van Duijnhoven SM, de Pooter M, Yetkin-Arik B, Wesseling P, Hendriks WJ, Venselaar H, Timmer M, van Cleef P et al (2015) Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein. Acta Neuropathol 130: 131\u2013144 https:\/\/doi.org\/10.1007\/s00401-015-1420-5","DOI":"10.1007\/s00401-015-1420-5"},{"key":"2271_CR16","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/sj.onc.1210201","volume":"26","author":"P Peschard","year":"2007","unstructured":"Peschard P, Park M (2007) From Tpr-Met to Met, tumorigenesis and tubes. Oncogene 26:1276\u20131285. https:\/\/doi.org\/10.1038\/sj.onc.1210201","journal-title":"Oncogene"},{"key":"2271_CR17","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/nm.4204","volume":"22","author":"ICGCPT Project","year":"2016","unstructured":"Project ICGCPT (2016) Recurrent MET fusion genes represent a drug target in pediatric glioblastoma. Nat Med 22:1314\u20131320. https:\/\/doi.org\/10.1038\/nm.4204","journal-title":"Nat Med"},{"key":"2271_CR18","doi-asserted-by":"publisher","unstructured":"Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD, Tang B, Haupfear K, Punchihewa C, Easton J et al (2016) Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol 131: 833\u2013845 https:\/\/doi.org\/10.1007\/s00401-016-1539-z","DOI":"10.1007\/s00401-016-1539-z"},{"key":"2271_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40478-020-00902-z","volume":"8","author":"S Ryall","year":"2020","unstructured":"Ryall S, Tabori U, Hawkins C (2020) Pediatric low-grade glioma in the era of molecular diagnostics. Acta Neuropathol Commun 8:30. https:\/\/doi.org\/10.1186\/s40478-020-00902-z","journal-title":"Acta Neuropathol Commun"},{"key":"2271_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","volume":"37","author":"S Ryall","year":"2020","unstructured":"Ryall S, Zapotocky M, Fukuoka K, Nobre L, Guerreiro Stucklin A, Bennett J, Siddaway R, Li C, Pajovic S, Arnoldo Aet al et al (2020) Integrated Molecular and Clinical Analysis of 1,000 Pediatric Low-Grade Gliomas. Cancer Cell 37:569\u2013583e565. https:\/\/doi.org\/10.1016\/j.ccell.2020.03.011","journal-title":"Cancer Cell"},{"key":"2271_CR21","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jtho.2016.06.004","volume":"11","author":"AB Schrock","year":"2016","unstructured":"Schrock AB, Frampton GM, Suh J, Chalmers ZR, Rosenzweig M, Erlich RL, Halmos B, Goldman J, Forde P, Leuenberger K al (2016) Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations. J Thorac Oncol 11:1493\u20131502. https:\/\/doi.org\/10.1016\/j.jtho.2016.06.004","journal-title":"J Thorac Oncol"},{"key":"2271_CR22","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1177\/1758834011422557","volume":"3","author":"JR Sierra","year":"2011","unstructured":"Sierra JR, Tsao MS (2011) c-MET as a potential therapeutic target and biomarker in cancer. Ther Adv Med Oncol 3:S21\u201335. https:\/\/doi.org\/10.1177\/1758834011422557","journal-title":"Ther Adv Med Oncol"},{"key":"2271_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nec.2018.08.002","volume":"30","author":"A Smits","year":"2019","unstructured":"Smits A, Jakola AS (2019) Clinical Presentation, Natural History, and Prognosis of Diffuse Low-Grade Gliomas. Neurosurg Clin N Am 30:35\u201342. https:\/\/doi.org\/10.1016\/j.nec.2018.08.002","journal-title":"Neurosurg Clin N Am"},{"key":"2271_CR24","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1093\/neuonc\/noq092","volume":"12","author":"T Stokland","year":"2010","unstructured":"Stokland T, Liu JF, Ironside JW, Ellison DW, Taylor R, Robinson KJ, Picton SV, Walker DA (2010) A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). Neuro Oncol 12:1257\u20131268. https:\/\/doi.org\/10.1093\/neuonc\/noq092","journal-title":"Neuro Oncol"},{"key":"2271_CR25","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1158\/2159-8290.CD-20-0495","volume":"10","author":"F Szulzewsky","year":"2020","unstructured":"Szulzewsky F, Cimino PJ (2020) Fusing the Genetic Landscape of Infantile High-Grade Gliomas. Cancer Discov 10:904\u2013906.","journal-title":"Cancer Discov"},{"key":"2271_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.21037\/cco-22-120","volume":"12","author":"DL Thomas","year":"2023","unstructured":"Thomas DL (2023) 2021 updates to the World Health Organization classification of adult-type and pediatric-type diffuse gliomas: a clinical practice review. Chin Clin Oncol 12:7. https:\/\/doi.org\/10.21037\/cco-22-120","journal-title":"Chin Clin Oncol"},{"key":"2271_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s40478-020-00980-z","volume":"8","author":"M Torre","year":"2020","unstructured":"Torre M, Vasudevaraja V, Serrano J, DeLorenzo M, Malinowski S, Blandin AF, Pages M, Ligon AH, Dong F, Meredith DM al (2020) Molecular and clinicopathologic features of gliomas harboring NTRK fusions. Acta Neuropathol Commun 8:107. https:\/\/doi.org\/10.1186\/s40478-020-00980-z","journal-title":"Acta Neuropathol Commun"},{"key":"2271_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/pap.0000000000000049","volume":"22","author":"S Venneti","year":"2015","unstructured":"Venneti S, Huse JT (2015) The evolving molecular genetics of low-grade glioma. Adv Anat Pathol 22:94\u2013101. https:\/\/doi.org\/10.1097\/pap.0000000000000049","journal-title":"Adv Anat Pathol"},{"key":"2271_CR29","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1111\/cas.70071","volume":"116","author":"K Watanabe","year":"2025","unstructured":"Watanabe K, Ogawa M, Shinozaki-Ushiku A, Tsutsumi S, Tatsuno K, Aburatani H, Kage H, Oda K (2025) Real-World Data Analysis of Genomic Alterations Detected by a Dual DNA-RNA Comprehensive Genomic Profiling Test. Cancer Sci 116:1984\u20131995. https:\/\/doi.org\/10.1111\/cas.70071","journal-title":"Cancer Sci"},{"key":"2271_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s10014-020-00377-9","volume":"37","author":"HY Woo","year":"2020","unstructured":"Woo HY, Na K, Yoo J, Chang JH, Park YN, Shim HS, Kim SH (2020) Glioblastomas harboring gene fusions detected by next-generation sequencing. Brain Tumor Pathol 37:136\u2013144. https:\/\/doi.org\/10.1007\/s10014-020-00377-9","journal-title":"Brain Tumor Pathol"},{"key":"2271_CR31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.tranon.2018.02.020","volume":"11","author":"T Xu","year":"2018","unstructured":"Xu T, Wang H, Huang X, Li W, Huang Q, Yan Y, Chen J (2018) Gene Fusion in Malignant Glioma: An Emerging Target for Next-Generation Personalized Treatment. Transl Oncol 11:609\u2013618. https:\/\/doi.org\/10.1016\/j.tranon.2018.02.020","journal-title":"Transl Oncol"},{"key":"2271_CR32","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1634\/theoncologist.2020-0535","volume":"25","author":"Y Yu","year":"2020","unstructured":"Yu Y, Liu Q, Li W, Qu Y, Zhang Y, Liu T (2020) Identification of a Novel EHBP1-MET Fusion in an Intrahepatic Cholangiocarcinoma Responding to Crizotinib. Oncologist 25:1005\u20131008.","journal-title":"Oncologist"},{"key":"2271_CR33","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/ng.2611","volume":"45","author":"J Zhang","year":"2013","unstructured":"Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, Orisme W, Punchihewa C, Parker M, Qaddoumi I al (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45:602\u2013612. https:\/\/doi.org\/10.1038\/ng.2611","journal-title":"Nat Genet"},{"key":"2271_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12943-024-02027-6","volume":"23","author":"M Zuckermann","year":"2024","unstructured":"Zuckermann M, He C, Andrews J, Bagchi A, Sloan-Henry R, Bianski B, Xie J, Wang Y, Twarog N, Onar-Thomas Aet al et al (2024) Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapy. Mol Cancer 23:123. https:\/\/doi.org\/10.1186\/s12943-024-02027-6","journal-title":"Mol Cancer"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02271-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02271-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02271-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:36:26Z","timestamp":1776321386000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02271-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2271"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02271-5","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The patient provided informed consent prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient provided informed consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}